Adverse event reporting across clinical trials and post-market settings requires timely, accurate, and regulation-compliant processes. Viltis supports end-to-end adverse event intake, assessment, and submission workflows.
Our team ensures expedited reporting timelines are met while maintaining data quality and integration with your pharmacovigilance systems.